Ponvory Den Europæiske Union - dansk - EMA (European Medicines Agency)

ponvory

janssen-cilag international n.v.    - ponesimod - multipel sklerose, recidiverende-remitterende - immunosuppressiva - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.